Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review
Arch. endocrinol. metab. (Online)
; 61(2): 198-201, Mar.-Apr. 2017. tab
Article
en En
| LILACS
| ID: biblio-838424
Biblioteca responsable:
BR1.1
ABSTRACT
SUMMARY Severe hypertriglyceridemia accounts for up to 7% of all cases of acute pancreatitis. Heparin and insulin activate lipoprotein lipase (LPL), thereby reducing plasma triglyceride levels. However, the safety and efficacy of heparin and insulin in the treatment of hypertriglyceridemia-associated acute pancreatitis have not been well established yet. We successfully used heparin and insulin as first-line therapy in four consecutive patients with acute pancreatitis secondary to hypertriglyceridemia. In a literature search, we revised almost all reports published to date of patients managed successfully with this combination. Heparin and insulin appear to be a safe, effective, and inexpensive first-line therapy for hypertriglyceridemia-associated acute pancreatitis.
Texto completo:
1
Índice:
LILACS
Asunto principal:
Pancreatitis
/
Heparina
/
Hipertrigliceridemia
/
Hipoglucemiantes
/
Insulina
/
Anticoagulantes
Tipo de estudio:
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Arch. endocrinol. metab. (Online)
Asunto de la revista:
ENDOCRINOLOGIA
/
METABOLISMO
Año:
2017
Tipo del documento:
Article